Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
66700
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
Shares delivered during the month: 66,700 (new shares: 66,700; transferred treasury shares: 0)
発行済株式総数
Exercise ratio subject to the exercise restriction: 0.19% (66,700 shares delivered across all series / 34,666,419 listed shares at the time of payment for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month: ¥213.40, ¥207.58, ¥216.31, ¥213.40 and ¥216.31. Details of the adjustment clause were not disclosed.
Number of Stock Acquisition Rights
Total issued: 86,000; unexercised at the end of the month preceding the reporting month: 37,933; unexercised at month-end: 37,266
Most recent equity financing
8 December 2025: issuance of Series 25 stock acquisition rights (with an exercise price adjustment clause) (detailed amount not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Shares delivered during the month: 66,700 (new shares: 66,700; transferred treasury shares: 0) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 0.19% (66,700 shares delivered across all series / 34,666,419 listed shares at the time of payment for the issuance) |
| Exercise price | Exercise prices during the month: ¥213.40, ¥207.58, ¥216.31, ¥213.40 and ¥216.31. Details of the adjustment clause were not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 86,000; unexercised at the end of the month preceding the reporting month: 37,933; unexercised at month-end: 37,266 |
| Most recent equity financing | 8 December 2025: issuance of Series 25 stock acquisition rights (with an exercise price adjustment clause) (detailed amount not disclosed) |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the exercise status for September 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.